You need to upgrade your Flash Player

PONIARD PHARMACEUTICALS (PARD) 2.53 green arrow $0.16 (6.75%) 06:51PM (15 mins delay)


PARD
$2.53    $0.16  (6.75%)

You need to upgrade your Flash Player
Today 5d 1m 3m 1y 5y 10y
Last: $2.53 High: -
Prev Close: $2.37 Low: -
Open: - Mkt Cap: $83M
Change: $0.16 ( 6.75% ) 52Wk High: $9.14
Vol: 0 52Wk Low: $1.05
Avg Volume: 6,046,049 Shares: 34.96B
EPS: -1.35 PE Ratio: -

Start trading PARD with real money!

Company Description

A biopharmaceutical company focused on the development and commercialization of cancer therapy products.

What do you think about PARD?

140 characters max. Total left: 140
Also post on Twitter. (What is Twitter?)

Comments on PARD

Rob Dunn via Twitter
Nov 16 8:27 AM
long $PARD @ 1.72....gotta be a dead cat bounce coming here
Comment
investorslive via Twitter
Nov 16 8:21 AM
wooooooow $PARD
Comment
spmsnk via Twitter
Nov 16 8:20 AM
$pard glad i have 7.5 dec puts. hopefully the gains in those offset the premiums i paid for the calls
Comment
StocksMD via Twitter
Nov 16 8:12 AM
$CRXX ouch $PARD ouch ouch
Comment
Fayola Nicaisse via Twitter
Nov 16 7:57 AM
@johnwelshphd re:$PARD down 85% , HOLLY Cr*p!. That is scarry.
Comment
Brokerz bearish news via Twitter
Nov 16 7:54 AM
RT @OptionRadar - $PARD patience pays off, been holding the Dec. 5 puts on heavy bearish put activity there
Comment
John Welsh Phd via Twitter
Nov 16 7:52 AM
@IraBidermanDDS I personally think $PARD miss a big surprise. The risk/reward was not there for the SPEAR play, you can see why.
Comment
Joe Kunkle via Twitter
Nov 16 7:38 AM
$PARD patience pays off, been holding the Dec. 5 puts on heavy bearish put activity there
Comment

PONIARD PHARMACEUTICALS (PARD) Stock News & Analysis

stock news Poniard Pharmaceuticals' Gamble Doesn't Pay Off 11/18/2009 Seeking Alpha
stock news Tuesday Options Recap 11/17/2009 Seeking Alpha
stock news Poniard Pharmaceuticals Announces Updated Positive Clinical Data from Phase 2 Trial of Picoplatin in Colorectal Cancer and New Phase 1 Cardiac Safety Trial Results 11/17/2009 PR Newswire
stock news BioMed News Bytes: Cytori, Poniard, Alkermes, Spherix, CRXX, HGSI 11/17/2009 Seeking Alpha
stock news Monday Options Recap 11/16/2009 Seeking Alpha
stock news Movers and downers in the market for Monday the 16th 11/16/2009 US Equity News
stock news Poniard Pharmaceuticals Announces Pivotal Phase 3 SPEAR Trial of Picoplatin in Small Cell Lung Cancer Did Not Meet Primary Endpoint 11/16/2009 PR Newswire
stock news Poniard Pharmaceuticals to Host Conference Call and Webcast at 8:00 a.m. Eastern Time Tomorrow to Discuss Results of Pivotal Phase 3 SPEAR Trial in Small Cell Lung Cancer 11/15/2009 PR Newswire
stock news Semi-Annual Changes to the NASDAQ Biotechnology Index 11/13/2009 GlobeNewswire
stock news Poniard Pharmaceuticals to Present Updated Clinical Data from Phase 2 Trial of Picoplatin in Colorectal Cancer and Final Phase 1 Cardiac Safety Trial Results 11/10/2009 PR Newswire
stock news Poniard Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides a Corporate Update 11/03/2009 PR Newswire
stock news Poniard Pharmaceuticals to Host Third Quarter 2009 Financial Results Conference Call on November 3 10/27/2009 PR Newswire
stock news Options Trader Friday Outlook: Churn Baby Churn 10/23/2009 Seeking Alpha
stock news Monday Options Recap 10/19/2009 Seeking Alpha
stock news Marc J. Fagel of the U.S. Securities and Exchange Commission to Discuss SEC Enforcement at CBI's Biotech/Pharma Finance and Accounting Forum in San Francisco 10/07/2009 PR Newswire

Write Your Own Stock Analysis

Do you have a hot tip on a stock? Share it with our community. Get started by entering the company name or symbol below.



Make a suggestion for this page

Investing Channel Logo

Data powered by QuoteMedia (Terms of Use). Data delayed 15 minutes unless otherwise indicated.